2,192
Participants
Start Date
April 1, 2022
Primary Completion Date
March 20, 2023
Study Completion Date
March 20, 2023
Ad26/protein preF RSV Vaccine
Ad26/protein preF RSV vaccine will be administered as an IM injection.
Placebo
Matching Placebo will be administered as an IM injection
Kojunkai Daido Hospital, Nagoya
Kishiwada Tokushukai Hospital, Kishiwada
Nanbu Tokushukai Hospital, Shimajiri-Gun
Shohokai Toda Internal Medicine and Neurology Clinic, Akashi-shi
Doujin Memorial Meiwa Hospital, Chiyoda-ku
Fukuwa Clinic, Chūō
Tokyo Asbo Clinic, Chūōku
Tokyo-Eki Center-Building Clinic, Chūōku
Tenjin Sogo Clinic, Fukuoka
Seikoukai New Medical Research System Clinic, Hachioji-shi
Hiroshima Station Clinic, Hiroshima
Medical Corporation JR Hiroshima Hospital, Hiroshima
Teine Keijinkai Hospital, Hokkaido
Aso Co.,Ltd Iizuka Hospital, Iizuka
Seikokai Omi Medical Center, Kusatsu-shi
Tohno Chuo Clinic, Mizunami-shi
Chubu Tokushukai Hospital, Nakagami-gun
Hanabusakai Shimamura Memorial Hospital, Nerima-ku
Yotsubashi Clinic, Osaka
Satou Hospital Miyagi, Osaki-shi
Jakushikai Banno Clinic, Ōta-ku
Keichikai Shimokitazawa Tomo Clinic, Setagaya-ku
Clinical Research Hospital Tokyo, Shinjuku-ku
Ishinkai Oda Clinic, Shinjyuku-ku
Hanabusakai Shinei Clinic, Suginami-ku
Josuikai Olive Takamatsu Medical Clinic, Takamatsu
Ikebukuro Metropolitan Clinic, Tokyo-To
Kouwakai Kouwa Clinic, Toshima-ku
Senrichuo Ekimae Clinic, Toyonaka-shi
Tsuchiura Beryl Clinic, Tsuchiura-shi
Lead Sponsor
Janssen Pharmaceutical K.K.
INDUSTRY